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Effects of Prolonged Administration of
Phthalate Ester on the Liver*
by A. E. Ganning,t U. Brunk,§ C. Edlund,t A. Elhammer,*
and G. Dallnert*
Di(2-ethylhexyl)phthalate (DEHP) was administered to male rats in the diet at concentrations of 2.0,
0.2, and 0.02% for up to 102 weeks. Low doses resulted in moderate increases in certain hepatic enzymes
during the initial phase of exposure and in a continuous increase in the activities ofthese same enzymes
throughout the treatment period. An increased level ofdolichol and decreased concentration ofdolichyl-
P were observed. Furthermore, the rate ofprotein glycosylation diminished. Liver biopsies from patients
subjected to hemodialysis demonstrated an increased number of peroxisomes. Phthalate ester seems to
interfere with protein turnover, so that the half-life of total mitochondrial and microsomal protein is
considerably increased.
Introduction
Humans are exposed to low doses of plasticizers for
long periods of time. Most people take up plasticizers
from food, water, and air, but the individual level of
exposure variesgreatly, as wasdocumentedinthis sym-
posium. Those exposed to the highest levels of plasti-
cizers are found among dialysis and hemophilia patients
and in certain branches ofindustry. However, all of us
encounter plasticizers in our environment, and we have
to expect a certain risk from lifetime exposure (1,2).
The validity ofthe usual experimental model, involv-
ingadministration ofhigh doses ofplasticizerfor ashort
time and subsequent extrapolation ofthe data obtained
to low dose administration for a long period, can be
questioned on several counts. In addition, because plas-
ticizers do not demonstrate acute toxicity, most test
systems employed in present day toxicology are less
effective in evaluating the risks associated with expo-
sure to these compounds.
In the present study we approached this problem by
treating one group of rats with 2% di(2-ethyl-
hexyl)phthalate (DEHP) (thedosecommonlyemployed)
in the diet and treated other groups of animals with
doses 10 and 100 times lower. The experiment was con-
tinued over a 2-year period in order to determine
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whether certain hepatic chemical or enzymatic param-
eters are influenced by such long-term exposure.
Materials and Methods
The materials, experimental procedures, and ultra-
structural, chemical, and enzymatic measurements em-
ployed here are those currently used in our laboratory
and are described in the literature (3-5).
Results
Electron Microscopy of Liver Tissue
DEHP, like other peroxisome-inducing agents, has
promptand extensiveeffects ontherathepatocyte. The
numberofperoxisomes isincreaseddramatically. Other
characteristic alterationsincludechangesinthe sizeand
even disappearance of the core structure of these or-
ganelles. DEHP has an additional effect not shared by
otherperoxisome-inducing agents, namely, induction of
mitochondria.
Dialysis patients have a particularly high level ofex-
posure to DEHP, receiving 100 to 200 mg ofthis com-
pound two to three times per week. Ifphthalate esters
have effects onthe structure ofhumanhepatocytes, one
would expect such changes to appear some time after
the onset ofthe dialysis treatment. In Sweden it is not
possible to systematically obtain liverbiopsies from pa-
tients subjected to dialysis. In some cases, when biop-
sies were taken for diagnostic purposes, we were able
toanalyzethesesamplesundertheelectronmicroscope.
The structure of human peroxisomes is less charac-
teristic than in the rat, as this organelle in man is ofGANNING ETAL.
moderate density and lacks a core. Figue 1 illustrates Vkh i: } %=,f @ ,
a liver biopsy from a patient dialyzed for 1 month. Per-
oxisomes are visible only occasionally and are greatly
outnumbered by mitochondria. In another case, after ,
12monthsofhemodialysis(Fig. 2), appreciable numbers .1 .A
of peroxisomes are visible. As these patients did not , *-
receive any drugs known to affect peroxisomes, phthal- i *4
ate esters may be responsible for this change.
Protein Synthesis and Breakdown
The appearance of new membranes in rats treated
with DEHP is extensive and cannot occur without de
novo synthesis. Previously, we found that in the initial
phase ofDEHPtreatment, therate ofphospholipid syn-
thesis in the endoplasmic reticulum increased by about
20%. Judging from the level of incorporation of radio-,
active precursors intototalmicrosomalprotein, therate
ofprotein synthesisis alsoincreased (Fig. 3B). Thehigh *.
rate of incorporation in mitochondria is explained by _A-
increased mitochondrialproteinsynthesistogetherwith .
FIGURE 2. Electron micrograph of the liver of a patient following
12 months ofhemodialysis. The arrows point to peroxisomes. x
* f )9 v..4.. import ofcomponents synthesized extramitochondrially
6 :- wr * i->^" :4 (Fig. 3A).
'A¢_j ;l 7 Under steady-state conditions, the rate ofmembrane
synthesis is about the same as the rate of membrane
4 degradation. It is now well established that a number
ofdrugsthatinterfere withmembranebiosynthesis also _ alter the rate of breakdown. In order to examine this
tEES '_ possibility, we followed the disappearance of [35S]-me-
thionine from the total protein ofmitochondria, micro-
' somes, and supernatant (Fig. 4). DEHP treatment re-
sulted in an increase in the average half-life of
mitochondrial proteins from -6 days to -25 days. Ob-
viously, this decreased breakdown is an important fac-
tor in mitochondrial proliferation. The increase in av-
erage protein half-life for microsomes and supernatant
is more moderate, i.e., from -3.5 to -5.5daysand from
-2.5 to -5 days, respectively.
Effects on Dolichol and Dolichyl-P
FIGURE 1. Electron micrograph of the liver of a patient after 1 Alltissues andvirtuallyal biologicalmembranes con-
month ofhemodialysis. Human liver biopsy specimens were fixed t issus endir allbolicalmembranes con-
inglutaraldehyde immediatelyafterremoval. The arrowpointsto tam the polyisoprenoid compound dolichol (6). This lipid
aperoxisome. x 14,500. is present in milligram quantities in certain human tis-
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FIGURE 3. Effect of DEHP treatment on the incorporation of ra-
dioactive protein precursors. Rats were fed a diet containing 2%
DEHP for two days. 200 ,uCi [3H]leucine was then injected into
the portal vein at specified time points before sacrifice. Mitochon-
dria (A) and microsomes (B) were isolated and the radioactivity
bound to protein precipitated by trichloroacetic acid was deter-
mined.
A
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Doys of phtholote treatment
sues, but much lowerlevels are seenin rattissues. Only
a small portion of the total dolichol is phosphorylated
and participates as an obligatory intermediate in the
biosynthesis ofN-glycosidicallylinked oligosaccharides.
The exact function(s) of dolichol is not yet known, but
recent observations indicate that this lipid destabilizes
model membranes and increases fatty acid fluidity (7).
In control rats, hepatic mitochondrial membranes
contain low levels of dolichol. The microsomes demon-
strate a relatively low content ofthis lipid as well, even
though the endoplasmic reticulum is the site ofdolichol
biosynthesis (Table 1). On the other hand, lysosomes
have 15times moredolicholthanisfoundinmicrosomes.
Treatment ofratswith2%DEHPfor5weeksaffected
only the dolichol content oflysosomes, where this value
was tripled. In microsomes about 20% ofthe total dol-
ichol is phosphorylated. Almost all of the initial phase
of protein glycosylation occurs in the endoplasmic re-
ticulum and the evidence indicates that the phosphor-
ylated intermediate isundercertain conditions ratelim-
iting for sugar transfer from the nucleotide-sugar to
protein. In contrast to the free alcohol, the level of
dolichyl-P decreases substantially as a result of DEHP
FIGURE 4. Changes in the apparent half-lives of intracellular pro-
teins caused by DEHP treatment. Rats fed a diet containing 2%
DEHP for 2 days were subsequently injected with 0.5 mCi
[3S]methionine IP. The animals were then sacrificed at specified
time points afterthis injection. Mitochondria (A), microsomes (B),
and particle-free supernatant (C) were prepared. The TCA-pre-
cipitable radioactivity in these individual fractions was deter-
mined.
Table 1. Distribution ofdolichol and dolichyl-P in liver
subfractions after treatment of rats with 2% DEHP for 5 weeks.
,ug/mg Protein
Dolichol Dolichyl-P
Fraction Control Treated Control Treated
Homogenate 0.192 0.289 0.101 0.070
Heavy mitochondria 0.094 0.117 0.010 0.013
Light mitochondria 0.072 0.100 0.008 0.008
Heavy lysosomes 3.85 9.88 0.204 0.194
Light lysosomes 3.73 9.51 0.181 0.165
Microsomes 0.215 0.238 0.159 0.083
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treatment and this decrease is localized to the key
subfraction, the microsomes.
Lysosomal dolichol is changed not only in amount,
but also in composition during DEHP treatment (Table
2). Dolichols containing 17 and 18 isoprene residues de-
crease in amount during 57 weeks of treatment. The
amounts of longer dolichols, D19 and D20, gradually
increase during this period. This pattern of change has
not been observed previously (8).
The amount ofdolichol present in lysosomes increases
with age, and phthalate esters cause an additional in-
crease (Fig. 5). After8months ofdietaryadministration
of 2% DEHP, a fourfold increase is observed, which is
close to maximal. Both the 0.2% and the 0.02% dose of
dietary DEHP also resulted in significant elevations of
the polyisoprenoid contentin lysosomes. With these low
doses the effect is observed only afterdietary treatment
for a long period of time.
Many intracellular and secretory proteins are glyco-
sylated, a process that is important from a functional
point of view (9). Protein-bound oligosaccharide chains
may be involved in protein association with various
membranes orprotein transport within the endoplasmic
Table 2. Distribution of individual dolichols in the
mitochondrial-lysosomal fraction from rat liver after DEHP
treatment.
Weeks of DEHP Composition, % oftotal
treatment D17 D18 D19 D20 D21
0 12 38 34 11 5
18 8 39 39 13 6
33 5 30 41 17 7
57 4 28 42 19 7
oi
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FIGURE 5. Levels ofdolichol inthe mitochondrial-lysosomal fraction
isolated from rat liver. Rats were kept on a diet containing 2.0,
0.2, or 0.02% DEHP for 3-102 weeks.
reticulum-Golgi system. The decrease in dolichyl-P ob-
served here during treatment of rats with plasticizer
raises the question as to whether various glycosyltrans-
ferase systems are also affected. Three sugars present
in the oligosaccharide core ofglycoproteins, i.e., N-ace-
tyl-glucosamine (GlcNAc), mannose, and glucose, are
transported and collected in the membrane of the en-
doplasmic reticulum with the help of dolichyl-P or dol-
ichyl-PP. For this reason, the corresponding glycosyl-
transferases were assayed (Table 3). Transfer ofsugar
from UDP-GlcNAc and GDP-mannose to dolichyl-P,
and also to protein, is considerably decreased. In agree-
ment with findings in other systems, the UDP-glucose
transferase system is less sensitive and not affected to
any great extent.
Enzymic Pattern
Induced changes ofthe metabolism were followed by
analyses of the activities or amounts of some key en-
zymes. During the entire 102-week exposure to the
three levels of DEHP, we monitored a number of en-
zymes. Cyanide-insensitive palmitoyl-CoA dehydroge-
nase is one of the enzymes involved in peroxisomal ,B-
oxidation offatty acids. This enzyme is rapidly induced
(15-20 times) even during the early phase oftreatment
with the highest dose of DEHP (Fig. 6). Lowering the
dose 10-fold results in a slower, but continuous increase
in this dehydrogenase activity. After 2 years, the ac-
tivity is still increasing in this case, but has not yet
reached itsmaximallevel. Acontinuous elevationofthis
activity was also observed with 0.02% DEHP.
One of the major effects of DEHP is induction of
carnitine-mediated fatty acidtransport inmitochondrial
inner membranes. Carnitine acetyltransferase (CAT) is
the enzyme most rapidly induced, and Figure 7A illus-
trates the changes in this activity during the experi-
mental period. Carnitine acetyltransferase is induced
very rapidly 30-fold by the diet containing 2% DEHP;
within the first couple of weeks a striking increase is
observed. Similar to the situation with othermembrane
components, no further induction is possible for sterical
or chemical reasons. As is the case for cyanide-insen-
sitive palmitoyl-CoA dehydrogenase, at the two lower
doses of DEHP, carnitine acetyltransferase is induced
much more slowly, but there is a continuous increase
in activity.
With regard to components of the microsomal frac-
tion, no dramatic effects ofexposure to phthalate esters
Table 3. Glycosyltransferase activities in liver microsomes after
dietary administration of 2% DEHP to rats for 6 weeks.
cpm/mg Protein
nucleotide Dol-P monosaccharide Protein
substrate Control Treated Control Treated
UDP-GlcNAc 1559 826 589 308
GDP-Mannose 2385 1486 606 327
UDP-Glucose 1735 1462 451 445
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FIGURE 6. Palmitoyl-CoA dehydrogenase activity of rat liver ho-
mogenate. The enzyme activity was measured in the presence of
KCN.
have been found. One of few changes observed in this
case is induction ofthe cytochrome P-450 system (Fig.
7B), possibly because of its involvement in phthalate
ester metabolism. Initially, the microsomal content of
cytochrome P-450 increases in a manner similar to the
increase in NADPH-cytochrome c reductase activity.
However, unlike the other enzyme activities described
above, the level of cytochrome P-450 decreases again
uponprolonged exposure, although itis stillhigherthan
the control value. As expected, lower doses of DEHP
have little or no effect onthe totalamountofcytochrome
P-450.
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Effects of Metabolites
The metabolism of DEHP has been studied in detail
(10). It is well established that various modifications of
the side chain take place in vivo and that hydrolytic
cleavage also occurs. It is possible that the various ef-
fects observed after dietary administration ofthis plas-
ticizer are caused not by one, but by several different
metabolites. We have compared the effects of DEHP
with those of the monoester, the benzoate derivative,
phthalic acid, and the isolated side chain (Fig. 8). Both
DEHP and monoethylhexylphthalate (MEHP) effec-
tively induce peroxisomal ,-oxidation, while this effect
is completely absentwhen 2-ethylhexylbenzoate (EHB)
is administered (Table 4). Similarly, both phthalic acid
(PA) and 2-ethylhexanol (EH) lack the capacity for in-
duction. The specific activity of catalase is decreased
upon exposure to DEHP and increased by MEHP. Mi-
crosomal NADPH-cytochrome c reductase activity is
increased by DEHP and MEHP, but not by the other
metabolites.
Discussion
Possible chronic toxicity resulting from phthalate es-
ters is a difficult problem to investigate from several
points ofview. The levels that occurin ourenvironment
are low, but on the other hand, phthalate esters are
more widely distributed than any other chemicals (11).
Consequently, man is continuously exposed.
At present, we do not knowwhetherphthalate esters
are metabolized and the products are excreted com-
pletely or ifaccumulation in certain tissues occurs. Elu-
cidation ofthese problems obviously requires extensive
data.
It is virtually impossible to definitively establish del-
eterious effects oflow-dose exposure to plasticizers on
human health due to the time element involved. If we
1.5i B. Cytochrome P-450 in microsomes
o 1.0
0.
0-
cn
2%O, EHP
Q2%DEHP
0.02% DEHP Control
24 48 72 96
Weeks
FIGURE 7. Effect ofprolonged phthalate ester treatment on mitochondrial carnitine acetyltransferase and microsomal cytochrome P450. (A)
Carnitine acetyltransferase activities in isolated mitochondria. (B) Cytochrome P-450 levels in isolated microsomes.
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FIGURE 8. Chemical formulae of the metabolites tested in the ex-
periment documented in Table 4.
Table 4. Effects of DEHP and certain of its metabolites on some
enzymes in homogenates and microsomes prepared from rat
liver.a
NADPH-
Palmitoyl-CoA cytochrome c
Treatmentb oxidation' Catalased reductasee
Control 4.8 81 0.089
DEHP 28.8 49 0.142
MEHP 16.7 113 0.154
EHB 3.5 65 0.092
PA 4.2 70 0.095
EH 3.8 81 0.101
aThe compounds tested were administered ad libitum in the diet
at a level of2% for 2 weeks. Palmitoyl-CoA oxidation (in the pres-
ence of KCN) and catalase were measured in the homogenate;
NADPH-cytochrome c reductase activity was determined in iso-
lated microsomes.
bDEHP = di(2-ethylhexyl)phthalate; MEHP = mono(2-ethylhexyl)
phthlate; EHB = 2-ethylhexylbenzoate; PA = phthalic acid;
EH = 2-ethylhexanol.
cnmole NAD reduced/min/mg protein. dpumole H202 decomposed/min/mg protein.
e .imole cytochrome c reduced/min/mg protein.
assume, in analogy to certain other environmental pol-
lutants, that some bioaccumulation of phthalate esters
does occurwithtime, itmaytake 30 to40 yearstoreach
a toxic level. Extensive use of PVC materials was in-
troduced in the 1960s. This means that evaluation of a
possible human toxicity would have to wait until the
year 2000.
There are some situations where humans are exposed
to relatively large amounts of plasticizers (12,13). The
tubing used for hemodialysis is made of PVC material
and patients may thus receive as much as 500 to 600
mg DEHP/week. Other well-established medical pro-
cedures that result in administration of phthalates in-
clude systemic blood transfusion and injection of blood
products, e.g., to hemophilic patients.
For the past couple of years we have been able to
investigate liver biopsies from patients undergoing he-
modialysis for various periods of time. These biopsies
were takeninordertodiagnosepossiblehepatitis. Elec-
tron micrographs revealed that, as in the rat, peroxi-
some proliferation in human liver does occur. These
patients had not received any drugs known to have per-
oxisome-proliferating effects. On the other hand, they
were systematically exposed to phthalate esters in con-
nection with their two to three dialysis treatments per
week.
We are well aware of two problems in interpreting
these data. One is the general health condition of pa-
tients subjected to dialysis. Renal insufficiency and a
continuous suburemic state have significant effects on
general metabolism and on the function of various or-
gans. It will be a difficult taskto distinguish the specific
effect ofa foreign chemical compound from these other
effects. Another difficulty is in obtaining a sufficient
number of biopsies to allow statistical analysis of the
effect on peroxisomes. This is not possible in Sweden,
as biopsies may be taken only for diagnostic purposes
when diagnosis by other means is unreliable.
Phthalate esters have been tested in various in vitro
systems, but insufficient information about the toxicity
of these plasticizers has been obtained. At present, in
vivo experiments are also required and all such studies
to date have utilized high doses and short-time admin-
istration. The usualdietary dose ofDEHPis 2%, a dose
which gives considerable effects within a few weeks.
Here we have also chosen doses that are 10- and 100-
fold less; the latter dose approaches the level of expo-
sure in dialysis patients. With these doses we followed
the response during a 2-year period, i.e., most of the
rat's lifespan.
Although these studies with very low doses ofphthal-
ate esters may be more adequate models fromthe point
ofviewofhumantoxicology, theyalsoinvolveproblems.
Aging itself has effects on cellular structure and me-
tabolism, e.g., a significant increase in lysosomal doli-
chol. Furthermore, even a well-kept animal room is far
from beingfree ofchemicals, and theresult is a sizeable
background exposure to xenobiotics, particularly in ex-
perimentslastingyears(14). Finally, variouschemicals,
including plasticizers, have different effects on young
256EFFECTS OF PHTHALATE ESTER ON LIVER 257
and adultanimals. Forthisreason, long-term exposures
to phthalate esters were begunwith adultrats, but this
procedure does not accurately mirror the pattern of
human exposure.
The most apparent results oflong-term, low-dose ex-
posure to phthalate esters are effects which are initially
limited, butincrease in acontinuous, almostlinearman-
ner with prolonged exposure. Consequently, after suf-
ficiently long exposure, even a very low dose ofa plas-
ticizer could give the same effects as a high dose for a
short period oftime. According to this argumentation,
no threshold values for phthalates exist, i.e., any level
of intake continued over a sufficiently long period of
time can have deleterious effects. The major questions,
however, remain: Whatisthepreciseperiodofexposure
required fortoxic effects in humans with environmental
levels ofphthalate esters? Will this time period be com-
pleted during a life-span?
The pattern of changes in membranes and enzymes
which results from DEHP treatment is not very com-
mon (14), as it involves several intracellular compart-
ments. The complexity ofthese changes is alsorevealed
by studies of the biosynthesis and breakdown of indi-
vidual components. The considerable decrease in t½ for
total mitochondrial protein and for proteins in other
compartments as well indicates that the changes are
mediated not only by an increased synthesis, but also
by decreased breakdown. We have previously shown
thatthe rate ofphospholipid synthesis is increased dur-
ingthe initialphase ofphthalate treatment (3). Therate
ofphospholipid breakdown underthese same conditions
has not yet been investigated, but this rate may also
decrease.
Studies ofthe effect of DEHP treatment on the pat-
tern of individual dolichols explain certain functional
changes. The phosphorylated form of this lipid is an
obligatoryintermediate inglycoprotein synthesis and is
present chiefly in the endoplasmic reticulum. A number
ofobservations indicate that the level ofthis lipid may
be rate-limiting in certain glycosyltransferase reactions
(15,16). The extensive reduction ofmicrosomal dolichyl-
P content, together with modifications of the glycosyl
transferases, may be the explanation for the decrease
in protein glycosylation caused by DEHP. Since many
ofthe proteins that are synthesized in the endoplasmic
reticulum are glycoproteins with important enzymatic
or receptor functions, the possible functional conse-
quences ofsuch changes are obvious. It will be a future
task to identify the proteins whose states of glycosy-
lation are altered by DEHP treatment.
The presence of dolichol in different cellular organ-
ellesiswellestablished, butallthefunctionsofthislipid
are not yet clear. It is now known that a large portion
of the dolichol is associated with the membrane itself,
and that a portion is probably distributed as lipid par-
ticles in the lumen. Recent investigations have shown
that dolichol affects the structure ofmodel membranes
(7), which is likely to be true also for biological mem-
branes. The principal effects observed are membrane
destabilization and anincreaseinphospholipidfattyacid
fluidity, properties which are ofessential importance to
membrane function. Phthalates increasethelevelofdol-
icholinlysosomal membranes, leadingtodestabilization
and a possible increase in permeability. If some of the
lysosomal contents, such as hydrolytic enzymes, are re-
leased, the possible severity of the effects on the cell
are obvious.
An important task in future research on phthalate
ester toxicology will be to analyze the effects of indi-
vidual metabolites. It seems unlikely that so many di-
verse effects are caused by a single agent. The levels
ofdifferent metabolites, theirtissue and membrane dis-
tributions, and the extent of their binding to various
cellular macromolecules may explain on a molecular
level the effects in cellular function caused by DEHP.
Removal of one alkyl chain does not alter the pattern
of induction very greatly. Removal of one alkyl chain
plus its carboxyl group, however, abolishes all the bi-
ological effects caused by DEHP administration. It is
quite possible that minor modifications ofthe structure
ofthis compound reduce, for example, its effects on one
organelle, but not on another.
The work from the authors' laboratories was supported by grants
from the Swedish Medical Research Council.
The authors express their gratitude to Jonas Bergstrom at Hud-
dinge Hospital for his kind cooperation in obtaining human liverbiop-
sies.
REFERENCES
1. Thomas, J. A., and Northup, S. J. Toxicity and metabolism of
monoethylhexyl phthalate and diethylhexyl phthalate. A survey
ofrecentliterature. J. Toxicol. Environ. Health9: 141-152 (1982).
2. Ganning, A. E., Brunk, U., and Dallner, G. Phthalate esters and
their effect on the liver. Hepatology 4: 541-547 (1984).
3. Ganning, A. E., Brunk, U., and Dallner, G. Effects of dietary
di(2-ethylhexyl)phthalate on the structure and function ofrat he-
patocytes. Biochim. Biophys. Acta 763: 72-82 (1983).
4. Eggens, I., Chojnacki, T., Kenne, L., and Dallner, G. Separation,
quantitation and distribution of dolichol and dolichyl phosphate
in rat and human tissues. Biochim. Biophys. Acta 751: 355-368
(1983).
5. Arias, I. M., Doyle, D., and Schimke, R. T. Studies on the syn-
thesis and degradation of proteins of the endoplasmic reticulum
ofrat liver. J. Biol. Chem. 244: 3303-3315 (1969).
6. Dallner, G., and Hemming, F. W. Lipid carriers in microsomal
membranes. In: Mitrochondria and Microsomes (C. P. Lee, G.
Schatz, and G. Dallner, Eds.), Addison-Wesley, Reading, PA,
1981, pp. 655-681.
7. Valtersson, C., van Duyn, G., Verkleij, A. J., Chojnacki, T., de
Kruijff, B., and Dallner, G. The influence of dolichol, dolichol
esters and dolichyl phosphate on phospholipid polymorphism and
fluidity in model membranes. J. Biol. Chem. 260: 2742-2751
(1985).
8. Edlund, C., Ganning, A. E., and Dallner, G. The influence of
prolonged di(2-ethylhexyl)phthalate treatmentonthedolicholand
dolichyl-P content ofrat liver. Chem.-Biol. Interact. 57: 255-270
(1986).
9. Kornfeld, R., and Kornfeld, S. Structure of glycoproteins and
theiroligosaccharide units. In: TheBiochemistryofGlycoproteins
and Proteoglycans (W. J. Lennarz, Ed.), Plenum Press, New
York, 1980, pp. 1-73.
10. Albro, P. W., Tondeur, Y., Marbury, D., Jordan, S., Schroeder,
J., and Corbett, J. T. Polarmetabolites ofdi(2-ethylhexyl)phthal-
ate in the rat. Biochim. Biophys. Acta 760: 282-292 (1983).
11. EPA. Review on di(2-ethylhexyl)phthalate (DEHP). Environ-
mental Protection Agency, Washington, DC, 1981.258 GANNING ETAL.
12. Rock, G., Secours, V. E., Franklin, C. A., Chu, I., and Ville-
neuve, D. C. The accumulation of mono 2-ethylhexylphthalate
(MEHP) during storage ofwhole blood and plasma. Transfusion
18: 553-558 (1978).
13. Kevy, S., and Jacobson, M. Hepatic effects of the leaching of
phthalate ester plasticizer and silicon. Contrib. Nephrol. 36: 82-
89 (1983).
14. Dallner, G., and De Pierre, J. W. Membrane induction bydrugs.
Methods Enzymol. 96: 542-557 (1983).
15. Carson, D. D., and Lennarz, W. J. Inhibition of polyisoprenoid
and glycoprotein biosynthesis causes abnormal embryonic devel-
opment. Proc. Natl. Acad. Sci. (U.S.) 76: 5709-5713 (1979).
16. Potter, J. E. R., and Kandutsch, A. A. Increased synthesis and
concentration ofdolichylphosphateinmouse spleensduringphen-
ylhydrazine-induced erythropoiesis. Biochem. Biophys. Res.
Commun. 106: 691-696 (1982).